Loading clinical trials...
Loading clinical trials...
The Effect of Visual and Auditory Cueing Walker on Gait in Individuals With Parkinson's Disease Experiencing Freezing of Gait
The aim of this study was to investigate the effects of a visual and auditory cueing walker on freezing of gait during walking in patients with Parkinson\'s disease (PDF), compared to Parkinson patients without freezing of gait (PDNF).Sample size was calculated to detect a difference of 0.37 m/sec on mean velocity, with a deviation of 0.3 m/sec, two-sided 5% significance level, and power of 90%. Considering the expected 10% dropout rate, twelve subjects were included.Researcher R1 determined whether the subject was eligible for inclusion in the trial and researcher R2 carried out the gait analysis. Both examiners were unaware of group allocation. An independent researcher (R3) performed the clinical evaluation before the procedures started. Participants walked back and forth on a 7-meter walking path under two different conditions: without cues and with a walker providing visual and auditory cues. To assess the risk of falls in both groups, the \"Tinetti Balance and Gait Assessment\" was conducted. Additionally, the \"Dynamic Gait Index\" was used to evaluate the ability to adapt walking to varying task demands, and the Timed Up and Go Test (TUGT) was employed to determine walking speed.
This study suggests that a walker providing visual and auditory cues may improve daily walking in patients with Parkinson\'s disease with freezing of gait (PDF) and reduce the risk of falls in patients with Parkinson\'s disease without freezing of gait (PDNF) who exhibit hypokinetic gait patterns.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Nezahat Keleşoğlu Faculty of Health Sciences
Konya, Meram, Turkey (Türkiye)
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)
Start Date
June 10, 2023
Primary Completion Date
October 10, 2023
Completion Date
December 10, 2023
Last Updated
October 8, 2025
30
ACTUAL participants
Visual & Auditory Cueing Walker
OTHER
Lead Sponsor
Necmettin Erbakan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06113640